Europe Medicines Group Joins Initiative To Fight Fake Medicines 27/05/2016 by Intellectual Property Watch 1 Comment Share this:Click to share on Twitter (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to share on Facebook (Opens in new window)Click to email this to a friend (Opens in new window)Click to print (Opens in new window)Medicines for Europe, representing the generic, biosimilar, and medicines in Europe, announced today during a side event at the World Health Assembly, that it joined the Global Campaign to Fight Fake Medicines. Medicines for Europe said in a release that it “acknowledges the magnitude of the problem related to the existence and spread of fake medicines.” Fight the Fakes campaign “represents a great opportunity for a multi-stakeholder and multi-disciplinary collaboration,” said Adrian van den Hoven, Medicines for Europe director general. He also highlighted the fact that fake medicines are “illegal and dangerous.” According to the release, fake medicines can be branded or generic, prescription or over-the-counter medicines. Share this:Click to share on Twitter (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to share on Facebook (Opens in new window)Click to email this to a friend (Opens in new window)Click to print (Opens in new window) Related "Europe Medicines Group Joins Initiative To Fight Fake Medicines" by Intellectual Property Watch is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.